The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)benzo[d]isothiazole ID: ALA4476294
PubChem CID: 141745657
Max Phase: Preclinical
Molecular Formula: C22H23FN4S
Molecular Weight: 394.52
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Fc1ccc2[nH]cc(CCCN3CCN(c4nsc5ccccc45)CC3)c2c1
Standard InChI: InChI=1S/C22H23FN4S/c23-17-7-8-20-19(14-17)16(15-24-20)4-3-9-26-10-12-27(13-11-26)22-18-5-1-2-6-21(18)28-25-22/h1-2,5-8,14-15,24H,3-4,9-13H2
Standard InChI Key: JEVQGJKCQNMIHY-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
12.1285 -7.7014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1274 -8.5209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8354 -8.9299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8336 -7.2925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5422 -7.6978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5471 -8.5209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3314 -8.7708 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8114 -8.1019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3236 -7.4389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4207 -7.2929 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.5716 -6.6602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3699 -6.4856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6179 -5.7069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4162 -5.5323 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.9626 -6.1385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7578 -5.9666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0099 -5.1889 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4604 -4.5828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6587 -4.7544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8069 -5.0176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4154 -5.5631 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.1222 -5.1531 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.1377 -4.2704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9488 -4.3560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4265 -3.6973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0943 -2.9527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2798 -2.8708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8057 -3.5304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
1 10 1 0
9 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
14 19 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
20 21 2 0
21 22 1 0
22 24 1 0
23 20 1 0
17 20 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 394.52Molecular Weight (Monoisotopic): 394.1627AlogP: 4.67#Rotatable Bonds: 5Polar Surface Area: 35.16Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.22CX LogP: 5.29CX LogD: 4.41Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.53Np Likeness Score: -1.63
References 1. Gu ZS, Wang WT, Qian H, Zhou AN, Sun HB, Zhang QW, Li JQ.. (2019) Synthesis and antidepressant effect of novel aralkyl piperazine and piperidine derivatives targeting SSRI/5-HT1A/5-HT7., 29 (23): [PMID:31627993 ] [10.1016/j.bmcl.2019.126703 ]